CMC Documentation

Work with our subject matter experts to get your high quality CMC Documentation in place.

About Us Speak to our team

CMC Support

The Role of CDMOs in CMC Pharmaceutical Development

CMC documentation typically includes detailed information on the drug substance, the drug product, the manufacturing process, and the stability of the product over time. This also includes information on the equipment and facilities used in production, which must adhere to the required standards of hygiene and safety. Contract Development and Manufacturing Organisations (CDMOs) play a crucial role in CMC pharmaceutical development, ensuring that drugs move efficiently from the laboratory to commercial production. CMC drug development involves the essential processes of formulation development, manufacturing, and regulatory compliance, all of which determine a drug’s safety, efficacy, and quality. Given the complexity of pharmaceutical product development, partnering with a CDMO can streamline operations, mitigate risks, and reduce costs. 

Pharmaceutical companies face increasing pressure to accelerate drug development timelines, maintain high regulatory standards, and control costs. CDMOs bring deep expertise in drug formulation, preclinical formulation development, and manufacturing, helping companies navigate these challenges. By outsourcing to a CDMO, you gain access to specialised formulation services, pharmaceutical development capabilities, and industry-leading regulatory support. 

Our model is built around:

  • One-site delivery for seamless project execution
  • Embedded senior leadership on every project
  • Scalable science that evolves with your programme
  • Flexible, responsive partnerships tailored to biotech needs

When you are ready to begin your CDMO journey, Upperton specialises in:

Inhalation drug products (pulmonary delivery)
Oral solid dosage form tablets and capsules
Oral solid dosage forms (OSD)
Nasal drug delivery systems
Parenteral formulations

CMC Support

Why work with a CDMO to complete your CMC Documentation?

  • Expertise in Formulation Development

    CDMOs possess extensive knowledge in drug formulation and pharmaceutical product development. Their expertise ensures that active pharmaceutical ingredients (APIs) are effectively transformed into safe, effective, and stable drug products. This proficiency is vital during preclinical formulation development, where optimising a drug’s bioavailability and stability can significantly impact its success.

  • Comprehensive Pharmaceutical Development Services

    Beyond formulation, CDMOs offer a range of services encompassing the entire pharmaceutical development process. From initial formulation development to large-scale manufacturing, their integrated approach ensures consistency and quality at every stage. This comprehensive support is crucial for navigating the complexities of CMC drug development.

  • Regulatory Compliance and Risk Mitigation

    CDMOs are well-versed in the regulatory requirements governing pharmaceutical product development. Their familiarity with CMC guidelines ensures that all aspects of drug development meet the necessary standards, reducing the risk of regulatory setbacks.

Discuss your individual project requirements

Got questions around submitting IND/IMPD Documentation?

Speak to our SME team about your project.

Find out more About Us

Why Upperton

At Upperton, we specialise in the formulation and development of complex molecules, supporting a wide range of advanced drug delivery systems.

Our expertise spans:

By combining scientific excellence with practical development expertise, we help overcome the challenges of complex drug products and accelerate their path to clinic and market.

About Us

partnership

Why Partner with Upperton

We provide fully integrated services across every stage of drug product development:

Microscope and analysis equipment at the Upperton facility

One Site

Integrated, end-to-end capabilities delivered under one roof.

Upperton scientist examining a formulation flask

One Team

The same team from your early-stage development through to preparation for commercial launch.

Test tubes used in complex molecule formulation development

Complex Molecule Expertise:

Proven track record in solving formulation and delivery challenges.

Upperton senior leadership overseeing laboratory work

Executive Leadership on Every Project:

Direct access to experienced senior leadership for strategic oversight and decision-making.

#01

Related Services

#02

Related Content

CMC Documentation FAQs

CMC stands for Chemistry, Manufacturing, and Controls. It is an essential part of pharmaceutical development, focusing on the drug’s chemical composition, the manufacturing processes used, and the quality controls that ensure the final product meets regulatory standards. In CMC drug development, these components are systematically tested and documented to guarantee the drug’s safety, efficacy, and consistency from preclinical stages through to commercial production. 

Formulation development is a key part of CMC pharmaceutical development. It involves designing and optimising the drug’s pharmaceutical formulation to ensure it is stable, effective, and suitable for its intended use. The drug formulation must be carefully developed to maintain the active ingredient’s potency and bioavailability while meeting regulatory guidelines. This is critical in drug development CMC as it influences the product’s safety, stability, and performance during clinical trials and after market release. 

Preclinical formulation development is crucial in CMC pharmaceutical development because it ensures that the drug formulation is both effective and safe before entering clinical trials. During this stage, the drug’s stability, solubility, and bioavailability are tested in controlled environments. The insights gained help refine the pharmaceutical formulation development, ensuring that the product can progress to human trials with a solid foundation in its chemical and physical properties. 

Formulation services are provided by experts who specialise in creating and testing drug formulations. These services support formulation development by offering guidance and technical knowledge to ensure that a drug’s formulation is optimal for both efficacy and regulatory approval. In CMC pharmaceutical development, formulation services are essential for overcoming challenges related to stability, bioavailability, and scaling, which are all critical aspects of drug development CMC.  

CMC is central to the regulatory approval process because it ensures that the drug’s chemistry, manufacturing, and controls meet stringent safety and quality standards. Regulatory bodies, such as the FDA, require detailed CMC drug development documentation before approving a new drug. This includes information about the drug formulation, manufacturing processes, and stability data, which confirm that the drug will perform safely and effectively for patients once on the market. 

Download Information Sheet

We provide fully integrated services across every stage of drug product development.

This field is for validation purposes and should be left unchanged.